← SynDRA
CARBENOXOLONE
SynDRA canonical compound SYN0011880 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | HSD11B1 |
|---|
| Mechanism of action | 11-beta-HSD1 inhibitor |
|---|
| Indication | mouth inflammation | peptic ulcer disease (PUD) |
|---|
| Disease area | dental | gastroenterology |
|---|
All known targets
- HSD11B1
- GJA1
- GJC2
- PANX3
- PANX2
- PANX1
- Hsd11b2
- Hsd11b1
- HSD11B2
- GJE1
- GJD4
- GJD3
Mechanisms of action (all sources)
- 11-beta-HSD1 inhibitor
- HSD11B2 INHIBITOR
- 11-beta-hydroxysteroid dehydrogenase inhibitor
- HSD11B1 INHIBITOR
- 11-beta hydroxysteroid dehydrogenase inhibitor
Drug classes
- Anti-Ulcer Agents
- Gastrointestinal Agents
ATC classes
- A02B · DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
Cross-references
Synonyms
- biogastrone
- glycyrrhetinic acid hydrogen succinate
- carbenoxolone disodium salt
- carbenoxolone disodium
- carbenoxolone sodium
- Carbenoxolona
- UNII-MM6384NG73
- OBZHEBDUNPOCJG-WBXJDKIVSA-N
- MM6384NG73
- Carbenoxolone [INN:BAN]
- Carbenoxolonum [INN-Latin]
- Carbenoxolona [INN-Spanish]
- Carbenoxolonum
- EINECS 227-174-2
- CBO
- (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(4-hydroxy-4-oxobutanoyl)oxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid
- 3beta-Hydroxy-11-oxoolean-12-en-30-saeure hydogensuccinat
- 3beta-(3-Carboxypropionyloxy)-11-oxo-olean-12-en-30-saeure
- Carbeneoxolone
- Carbenoxalone
- Glycyrrhetinic acid hydrogen succinate
- RefChem:123513
- DTXCID702733
- A02BX01
- 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic Acid
- Acid 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic
- Carbenoxolone (INN)
- CARBENOXOLONE [INN]
- Prestwick0_000837
- Prestwick1_000837
- Prestwick2_000837
- Prestwick3_000837
- CARBENOXOLONE [MI]
- SCHEMBL76013
- BSPBio_000793
- SPBio_002714
- CARBENOXOLONE [WHO-DD]
- BPBio1_000873
Look up CARBENOXOLONE in the interactive SynDRA portal →